Brain oxygen monitoring system and intracranial monitoring system
By detecting fluorescence lifetime and integrating biocompatible oxygen-sensitive membranes and light sources, the problems of consumption of intracranial oxygen, fluorescence intensity is easily disturbed and optical signal transmission losses in existing brain oxygen monitoring technologies are solved, achieving high accuracy and low cost brain oxygen monitoring.
Patent Information
- Application Number
- CN202323128056.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-20
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2033-11-20
AI Technical Summary
The existing brain oxygen monitoring technology has problems such as consumption of intracranial oxygen, easy to interfere with fluorescence intensity, leakage of fluorescence indicators and loss of optical signal transmission, resulting in inaccurate monitoring results and high cost.
Using a method of detecting fluorescence lifetime, LEDs are used to replace traditional optical fibers, integrate biocompatible oxygen-sensitive films and light sources, integrate photoelectric processing devices to reduce optical signal loss, and directly insert them into the brain to monitor through miniaturized construction.
It improves the accuracy and stability of brain oxygen monitoring, reduces costs, reduces trauma risk to patients, and enhances the anti-interference ability of the device.
Smart Images

Figure CN221980739U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the field of innovative medical technology, in particular to an innovative brain oxygen monitoring system and an intracranial monitoring system. Background Art
[0002] Craniocerebral injury is one of the common clinical emergencies. It is mainly caused by various reasons that lead to ischemia and hypoxia of brain tissue, resulting in hypotension and hypoxemia.
[0003] Studies have shown that cerebral hypoxia can still occur without increased intracranial pressure (ICP) or decreased cerebral perfusion pressure. In addition, not all ischemia is associated with increased ICP. In this case, the partial pressure of brain tissue oxygen (P bt O 2 ) monitoring is beneficial to the prognosis of patients with craniocerebral injury. Moreover, extracellular metabolic disorders and mortality have been shown to be associated with P bt O 2 Level related, P bt O 2 It is not only related to ICP and CPP, but also to partial pressure of oxygen (P a O 2 ), body temperature, pH and other parameters, which are considered important reference indicators for guiding treatment and judging whether patients need it. bt O 2 >5mmHg to maintain normal cerebral cortical function, and the normal human body's P bt O 2 The range is 20 to 35 mmHg (1 mmHg = 0.133 kPa). If it is lower than 20 mmHg, timely treatment is required. bt O 2 A hypoxic state of 10 to 15 mmHg is mild, a hypoxic state of 5 to 10 mmHg is moderate, and a hypoxic state of less than 5 mmHg is severe. bt O 2 When the concentration is below 15 mmHg for 30 minutes or below 10 mmHg for 10 minutes, the risk of death will be greatly increased. bt O 2 Monitoring is particularly important.
[0004] Among the existing technologies, the three common brain oxygen saturation monitoring technologies are jugular venous oxygen saturation (S vj O 2 ) monitoring technology, near-infrared spectroscopy (NIRS) monitoring technology and brain tissue oxygen tension (brain tissue oxygen tension, P bt O 2 ) monitoring technology.
[0005] S vj O 2 As an interventional operation, as the monitoring time increases, problems such as hematoma, venous thrombosis, and insensitivity to local brain tissue ischemia may occur. There is a trend of it being replaced by other new monitoring technologies.
[0006] NIRS is a non-invasive brain oxygen saturation monitoring technology based on the transmission and absorption of near-infrared light (wavelength range 700-950nm) through tissues. It determines the concentration of chromophore biomolecules by determining their different optical densities and relative absorption wavelengths in the near-infrared spectrum. However, problems such as signal interference from extracranial tissues and contamination caused by extracranial circulation limit the accuracy of NIRS monitoring. The above two monitoring technologies both indirectly reflect the metabolism of brain tissue. Both have low sensitivity and are susceptible to inaccurate monitoring results due to problems such as light intensity, catheter position, and changes in the patient's head.
[0007] P bt O 2 Monitoring is a technical method based on lesion measurement to insert a single electrode or multi-parameter sensor into the brain tissue to dynamically monitor indicators such as oxygen partial pressure, pH value and brain temperature. It directly obtains indicators of brain oxidation and metabolism, and provides the most direct basis for early clinical detection of cerebral ischemia and hypoxia. It is not only accurate, anti-interference, safe, and easy to operate, but also not affected by the patient's head position.
[0008] P bt O 2 There are currently two types of monitoring equipment: the Licox system, which uses Clark electrodes to monitor P bt O 2 The sampling range is about 14mm. 2; and the Neurovent-PTO system (RAUMEDIC), which guides the light path through an optical fiber and a puncture needle, uses an oxygen-sensitive membrane for fluorescence quenching reaction, and provides regional and continuous monitoring through the fluorescence quenching process to measure the oxygen content in the adjacent brain tissue. It can also simultaneously monitor carbon dioxide partial pressure, pH value and brain temperature, with a sampling range of approximately 22mm 2 .
[0009] Problems and shortcomings of existing technologies:
[0010] The Clark electrode principle used by the Licox system is based on the fact that oxygen diffused from brain tissue is reduced by the electrode in the electrolyte to generate current, and the measurement is completed through the current proportional to the oxygen concentration. This reaction process must involve oxygen. In the case of a closed brain and hypoxia of the patient's brain tissue, if the intracranial oxygen is consumed after long-term monitoring, the measurement of oxygen concentration will be biased.
[0011] The Neurovent-PTO system is based on the detection principle of fluorescence quenching: in the presence of oxygen, a pulse signal excitation light LED is given, and the fluorescence intensity of the fluorescence indicator fixed in the silica gel matrix is quenched by the excitation light to measure, but the fluorescence intensity is easily affected by factors such as light source fluctuations and leakage of fluorescent indicators. In addition, since it is necessary to connect an optoelectronic processing device at the end of the optical fiber to process the optical signal, and the damage caused by the refraction of the optical signal inside the optical fiber during transmission is inevitable, the reduction in quantum efficiency will cause deviations in the results.
[0012] The price of optical fiber and external optoelectronic processors are usually high, and integrating multiple modules into a small optoelectronic device has corresponding technical and process difficulties.
[0013] Therefore, the industry needs improved devices and systems for characterizing and measuring cerebral oxygen saturation to alleviate or overcome the deficiencies of the prior art and achieve more beneficial technical effects and progress.
[0014] The information included in this background section of the present specification, including any references cited herein and any description or discussion thereof, is included for technical reference purposes only and is not to be considered as subject matter that will limit the scope of the present invention. Summary of the invention
[0015] Brain tissue oxygen monitoring is of great significance and importance in the field of clinical medicine. Brain hypoxia can still occur without increased intracranial pressure (ICP) or decreased cerebral perfusion pressure.bt O 2 ) and other multimodal monitoring of critical neurological diseases can benefit the prognosis of patients with craniocerebral injury. In patients under general anesthesia or sedation, when brain tissue ischemia and hypoxia are not easily detected, brain tissue oxygen monitoring plays an important guiding role in assisting doctors in judging the severity of neurosurgical diseases, preventing secondary brain injury, and treating and prognosing moderate to severe craniocerebral injuries. Brain tissue oxygen monitoring can directly obtain indicators of brain oxidation and metabolism, measure brain tissue oxygen supply, and provide a basis for early clinical detection of cerebral ischemia and cerebral hypoxia.
[0016] In view of the above and other more ideas, the present utility model is proposed.
[0017] According to one aspect of the present invention, a brain oxygen monitoring system is provided. The basic concept and objectives of the brain oxygen monitoring system of the present invention at least include the following:
[0018] Compared with Licox products, it improves or even eliminates the disadvantage of consuming oxygen in the patient's body (especially in the patient's brain);
[0019] Compared with Neurovent products, 1) by using fluorescence lifetime detection, the disadvantage of fluorescence intensity being easily interfered with is improved or even eliminated; 2) LED is used instead of traditional optical fiber or photodiode to achieve the goal of reducing costs and facilitating integration and miniaturization of devices, which is very critical and necessary for devices implanted in the brain; 3) biocompatible oxygen sensitive membrane is used to improve or even eliminate the disadvantage of easy leakage of fluorescent indicators and improve the stability of oxygen sensor devices; 4) light source, fluorescent membrane and photoelectric processing device are integrated together to solve the problem of optical signal loss during transmission;
[0020] The overall integrated structure and process method make the device miniaturized. The brain oxygen sensor part can be directly inserted into the patient's brain, and can solve the defects of the prior art such as the need for an external optoelectronic processor, easy trauma to the patient during implantation, and high device cost.
[0021] According to one aspect of the present invention, a brain oxygen monitoring system is provided, comprising: a microcontroller; a brain oxygen sensor communicatively connected to the microcontroller; wherein the brain oxygen sensor comprises: a circuit board; a photoelectric conversion device mounted on the circuit board and electrically connected thereto; a filter film coated on the surface of the photoelectric conversion device to filter out noise light; a biocompatible oxygen-sensitive film stacked on the filter film, wherein the oxygen-sensitive film contains a fluorescent indicator; an excitation light source and a reference light source separately arranged on the oxygen-sensitive film; wherein the fluorescent indicator is selected so that the fluorescence excited by the excitation light source can be captured and processed by the photoelectric conversion device; wherein the lifetime of the fluorescence is characterized by the phase difference between the light emitted by the reference light source and the fluorescence excited by the excitation light source at the same frequency; wherein the brain oxygen monitoring system is configured to associate the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure with the phase difference to achieve monitoring of the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure.
[0022] According to one embodiment, a circuit board includes a signal conditioning circuit.
[0023] According to one embodiment, the photoelectric conversion device includes a silicon photomultiplier tube.
[0024] According to one embodiment, the photoelectric conversion device, the filter film, the oxygen sensitive film, the excitation light source and the reference light source are integrated into an integral structure.
[0025] According to one embodiment, the fluorescent indicator is selected such that the wavelength and lifetime of the fluorescent light are both suitable for being effectively captured and processed by the photoelectric conversion device.
[0026] According to an embodiment, the silicon photomultiplier tube is a silicon photomultiplier tube with a multi-pixel photon counter function, and is composed of a plurality of avalanche photodiodes operating in Geiger mode.
[0027] According to one embodiment, the excitation light source and the reference light source are an excitation light LED and a reference light LED respectively; and the filter film, the oxygen sensitive film, the excitation light LED and the reference light LED are integrated on the silicon photomultiplier tube through coating and packaging.
[0028] According to one embodiment, the circuit board further includes an LED driving circuit, a constant current power supply circuit and an IV conversion circuit.
[0029] According to one embodiment, the brain oxygen monitoring system is configured to control the light emission of both the excitation light source and the reference light source by modulating a current signal of a sine wave with the same frequency through a microcontroller and a circuit board.
[0030] According to another aspect of the present invention, an intracranial monitoring system is provided, characterized in that the intracranial monitoring system comprises a brain oxygen monitoring system as described above; and a monitor, wherein the monitor comprises a display for displaying physiological parameters of the monitored patient, the physiological parameters comprising the patient's brain tissue oxygen concentration and / or brain tissue oxygen partial pressure.
[0031] According to one embodiment, the circuit board is an electromagnetically compatible flexible circuit board;
[0032] A pressure sensor for monitoring intracranial pressure and a temperature sensor for monitoring intracranial temperature are also integrated on the flexible circuit board; and the temperature sensor is configured to also be used for temperature compensation of both the brain oxygen sensor and the pressure sensor.
[0033] According to an embodiment, the pressure sensor is an absolute pressure sensor.
[0034] According to one embodiment, the absolute pressure sensor, the temperature sensor and the brain oxygen sensor are integrated and packaged on the end of the flexible circuit board that is placed at the catheter tip; or, the absolute pressure sensor and / or the temperature sensor and / or the signal chain chip are integrated and packaged on a micro circuit board, wherein the micro circuit board is integrated and electrically connected to the end of the flexible circuit board that is placed at the catheter tip.
[0035] According to an embodiment, the absolute pressure sensor may be exposed from the catheter tip, and preferably, the absolute pressure sensor may be covered by a protective shell.
[0036] According to an embodiment, the signal transmission line is a digital signal transmission line designed to transmit digital signals.
[0037] According to one embodiment, it further includes a back-end circuit integrated in or connected to the rear end of the flexible circuit board through a connector, and the back-end circuit includes at least one of a filtering circuit, an amplifying circuit, an A / D converter and a D / A converter.
[0038] According to one embodiment, the backend circuit further includes an integrated wireless communication chip.
[0039] According to an embodiment, the width of the strip-shaped flexible circuit board does not exceed 3 mm, for example, is in the range of 1-2 mm, and is preferably less than 0.8 mm.
[0040] According to one embodiment, a micro circuit board in the form of a micro rigid substrate is electrically connected to the flexible circuit board via a conductive adhesive.
[0041] According to an embodiment, the area of the absolute pressure sensor is less than 2 square millimeters, for example less than 1 square millimeter.
[0042] According to an embodiment, the length of the strip-shaped flexible circuit board is greater than 80 mm, for example, greater than 200 mm.
[0043] According to an embodiment, the length of the strip-shaped flexible circuit board is in the range of 400-1500 mm.
[0044] According to an embodiment, the flexible circuit board is a single-sided circuit board or a double-sided circuit board, and electromagnetic shielding protection layers are provided on both the front and back sides of the flexible circuit board.
[0045] According to one embodiment, the flexible circuit board is a double-sided circuit board based on a flexible copper clad laminate, wherein an absolute pressure sensor, a temperature sensor, and a brain oxygen sensor are arranged on the front side of the double-sided circuit board, and a power supply line is arranged on the back side of the double-sided circuit board.
[0046] According to an embodiment, the electromagnetic shielding layer is selected from at least one of the following: a silver foil, a copper foil, a silver-containing coating, and a copper plating layer.
[0047] According to an embodiment, the temperature sensor is a sensor in the form of an NTC (Negative Temperature Coefficient Thermistor).
[0048] According to one embodiment, the temperature sensor is a PN junction temperature sensor integrated on the signal chain chip.
[0049] Many other embodiments of the present invention can also achieve other advantageous technical effects that are not listed one by one. These other technical effects may be partially described below and are predictable and understandable to those skilled in the art after reading the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] The above features and advantages of these embodiments and other features and advantages and the manner in which they are achieved will become more apparent, and the embodiments of the present invention can be better understood by referring to the following description together with the accompanying drawings, in which:
[0051] Figure 1 Schematic diagram of the general configuration of a brain oxygen sensor according to the first embodiment of the present invention.
[0052] Figure 2 The performance and comparison of indicator parameters of some fluorescent indicators are shown.
[0053] Figure 3 Schematic diagram of an exemplary configuration of a brain oxygen sensor according to a second embodiment of the present invention.
[0054] Figure 4 It is a schematic block diagram of a partial configuration of an intracranial monitoring system with an integrated brain oxygen sensor according to an embodiment of the present invention. DETAILED DESCRIPTION
[0055] In the following description of the drawings and specific embodiments, the details of one or more embodiments of the present utility model will be described. From these descriptions, drawings and claims, other features and advantages of the present utility model can be clearly seen.
[0056] It should be understood that the illustrated and described embodiments are not limited in application to the details of the construction and arrangement of the components set forth in the following description or illustrated in the accompanying drawings. The illustrated embodiments may be other embodiments and may be implemented or executed in various ways. Each example is provided by explaining the disclosed embodiments rather than limiting them. In fact, it will be apparent to those skilled in the art that various modifications and variations may be made to the various embodiments of the utility model without departing from the scope or essence disclosed in the utility model. For example, a feature illustrated or described as part of an embodiment may be used together with another embodiment to still produce another embodiment. Therefore, the utility model discloses such modifications and variations that fall within the scope of the appended claims and their equivalent elements.
[0057] It is also understood that the terms used herein are for descriptive purposes and should not be considered restrictive. The use of "include", "comprises", or "having" and variations thereof herein is intended to openly include the items listed thereafter and their equivalents and additional items.
[0058] The present invention will be described in more detail below with reference to specific embodiments of the present invention.
[0059] First embodiment
[0060] According to the first embodiment of the utility model, a brain oxygen sensor 10 is provided to solve the problems that the conventional electrochemical technology has the problem of the deviation of the measurement result of oxygen concentration, and the fluorescence intensity detection technology system is easily affected by factors such as light source fluctuation and fluorescence indicator leakage. Figure 1 The brain oxygen sensor 10 will be described.
[0061] The exemplary brain oxygen sensor 10 provided in the first embodiment of the present application is Figure 1 As shown, Figure 1 This is a schematic diagram of the structure of the brain oxygen sensor 10 provided in the first embodiment of the present application. The brain oxygen sensor 10 of the present application can be used for real-time monitoring of the intracranial brain oxygen content of a patient.
[0062] In order to more clearly illustrate the structure of the brain oxygen sensor 10 , the brain oxygen sensor 10 will be introduced below with reference to the accompanying drawings.
[0063] See also Figure 1 As shown, Figure 1The structure diagram of the brain oxygen sensor 10 provided according to the first embodiment of the utility model is shown in FIG. A brain oxygen sensor 10 includes a circuit board 100, a silicon photomultiplier tube 200, a filter 300, an excitation light source 400, a reference light source 500, an oxygen sensitive film 600, and a thermistor device 700. The silicon photomultiplier tube 200 is mounted on the circuit board 100 and electrically connected to the circuit board 100. The filter 300 is arranged on the silicon photomultiplier tube 200. The excitation light source 400 and the reference light source 500 are arranged on the filter 300 in a relative manner. The oxygen sensitive film 600 is arranged on the filter 300 and is located between the excitation light source 400 and the reference light source 500. The oxygen sensitive film 600 contains a fluorescent indicator. The thermistor device 700 (NTC) is electrically connected to the circuit board 100. The thermistor device 700 serves as a calibrated temperature sensor.
[0064] The brain oxygen sensor 10 attaches and fixes the excitation photodiode, the reference photodiode and the oxygen sensitive film 600 containing the fluorescent indicator to reduce the loss of light in the emission path. The silicon photomultiplier tube 200 with a multi-pixel photon counter function is selected for photoelectric signal processing, and the filter 300 is directly plated on the surface of the silicon photomultiplier tube 200 through a coating process, and the excitation photodiode and the reference photodiode are integrated in the same plane, so as to achieve the purpose of reducing the loss of light signals caused by passing through the filter 300.
[0065] According to an example, the silicon photomultiplier tube 200 may be a 10035 model silicon photomultiplier tube from ONSEMI.
[0066] According to an example, the circuit board 100 may be a flexible circuit board 100 .
[0067] According to one example, the fluorescent indicator is a transition metal complex.
[0068] According to an example, the fluorescent indicator is selected from one or both of PtOEP and PtTFPP. For example, in a specific embodiment, the fluorescent indicator is PtTFPP, which is called tri-5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin platinum in Chinese.
[0069] According to an example, the excitation light source 400 is an excitation photodiode.
[0070] According to an example, the wavelength of the excitation light source 400 is 300-550 nm, for example, the wavelength of the excitation light source 400 is 650 nm.
[0071] According to an example, the reference light source 500 is a reference photodiode.
[0072] According to an example, the wavelength of the reference light source 500 is 380-660 nm, for example, the wavelength of the reference light source 500 is 405 nm.
[0073] For example, according to one example, the preparation method of the oxygen sensitive film 600 includes the following steps: dissolving the fluorescent material transition metal complex powder in an ethanol solution and then uniformly stirring the mixture with silica particles and a sodium hydroxide aqueous solution at a speed of 2000-3000 rpm for 30-60 minutes to form a silica gel solution; filtering the mixed solution through a filter to obtain dye-loaded silica particles, washing the dye-loaded silica particles and drying them at 60°C-90°C overnight; fully mixing the dried precipitate, PDMS prepolymer and PDMS curing agent, and preparing a 100μm-500μm thick film by spin coating with a spin coater, and curing the film at 50°C-80°C to obtain the oxygen sensitive film 600.
[0074] For another example, according to an example, a preparation method of an oxygen-sensitive film 600 includes the following steps: dissolving a fluorescent material transition metal complex powder in an ethanol solution to form a fluorescent solution; adding carrier silica particles to an aqueous sodium hydroxide solution, and magnetically stirring the mixture at 2000-3000 rpm for 30-60 minutes using a magnetic stirrer to form a silica gel solution; adding the fluorescent solution to the silica gel solution, and continuing to stir the mixture at 2000-3000 rpm for 30-60 minutes to form a mixed solution; filtering the mixed solution through a filter to obtain dye-loaded silica particles, washing the dye-loaded silica particles, removing the supernatant, and drying the precipitate; fully mixing the dried precipitate, PDMS prepolymer, and PDMS curing agent, and spin coating the dried film to prepare a 100 μm-500 μm thick film using a spin coater, and curing the film at 50°C-80°C to obtain the oxygen-sensitive film 600.
[0075] According to an example, an excitation photodiode of 300 to 550 nm (e.g., a blue LED) can be used as an excitation light source 400, and a reference photodiode of 380 to 660 nm (e.g., an orange / red LED) can be used as a reference light source 500. The above-mentioned brain oxygen sensor 10 uses silicon dioxide particles as a carrier for filling fluorescent indicators, and then mixes them in a silica gel matrix as an oxygen sensitive membrane 600 to solve the problem of leakage of fluorescent indicators in traditional technologies. Since the fluorescence lifetime is an intrinsic parameter of the fluorescent indicator itself and is not easily affected by external factors, the fluorescence lifetime measurement method is selected to replace the fluorescence intensity measurement method, and a silicon photomultiplier tube 200 (Sipm) with a multi-pixel photon counter function is used for photoelectric signal processing, and the distance between the oxygen sensitive membrane 600 containing the fluorescent indicator and the photoelectric processor is shortened to reduce the loss of optical signals during transmission.
[0076] According to an example, the mass ratio of the precipitate (2 grams), the PDMS prepolymer (20 grams) and the PDMS curing agent (2 grams) is (1-2): (10-20): (1-2). In the above-mentioned brain oxygen sensor 10, when preparing the oxygen sensitive membrane 600, polydimethylsiloxane (PDMS) is selected instead of the traditional material as the polymer matrix. PDMS not only has excellent oxygen permeability, biocompatibility, optical transparency and high solubility for fillers, but also can prevent the fluorescent dye from aggregating in the gel, solving the problem of leakage of the fluorescent indicator in the traditional technology.
[0077] For example, in one specific example, 2 grams of precipitate, 20 grams of PDMS prepolymer, and 2 grams of PDMS curing agent are used.
[0078] According to one example, the brain oxygen sensor 10 also includes at least one of the following features: the mass volume ratio of the fluorescent material to the ethanol solution is 10:1-20:1 (mg / mL); the mass volume ratio of the carrier silica particles to the sodium hydroxide aqueous solution is 1:40-2:40 (mg / mL); the mass ratio of the fluorescent material to the carrier silica particles is 1:10-1:20.
[0079] For example, in a specific example, the method for preparing the oxygen sensitive film 600 includes the following steps:
[0080] 200 mg of fluorescent material PtTFPP powder was dissolved in 10 mL of ethanol solution to form a fluorescent solution;
[0081] 2 g of carrier silica particles were added to 40 mL of sodium hydroxide aqueous solution and stirred evenly with a magnetic stirrer to form a silica gel solution;
[0082] Add the fluorescent solution into the silica gel solution and continue to stir evenly to form a mixed solution;
[0083] The mixed solution was filtered to obtain dye-loaded silica particles, the dye-loaded silica particles were washed 5 times, the supernatant was removed, and the precipitate was dried at 70° C. overnight;
[0084] The dried 2 g precipitate, 20 g PDMS prepolymer and 2 g PDMS curing agent were fully mixed, and a 100-500 μm thick film was prepared by spin coating at a speed of 500 rpm. The film was cured in a vacuum environment at 70° C. to obtain an oxygen sensitive film 600, which was stored at room temperature in a dark environment for later use.
[0085] At least one embodiment of the utility model provides a monitoring device. The monitoring device includes a PC terminal (computer terminal), a microcontroller, a signal amplifier, an oscilloscope and a brain oxygen sensor 10, the PC terminal is electrically connected to the excitation light source 400 and the reference light source 500 of the brain oxygen sensor 10 through the microcontroller, the signal amplifier is connected to the silicon photomultiplier tube for amplifying the current signal, the oscilloscope is connected to the signal amplifier for reading the waveform of the corresponding phase, and the oscilloscope is also electrically connected to the PC terminal. The intracranial brain oxygen content monitoring device of the present application can be used for real-time monitoring of the intracranial brain oxygen content of patients.
[0086] When the above monitoring device is used, the following steps may be included:
[0087] A pulse signal is given to the microcontroller unit (MCU) through the PC terminal control. The pulse signal causes the excitation light source 400 and the reference light source 500 to emit at the same time. The excitation light source 400 reaches the oxygen sensitive film 600 and undergoes a fluorescence quenching reaction, which excites the fluorescence affected by the oxygen molecule content. The fluorescence signal is transmitted to the silicon photomultiplier tube 200 for processing to realize photoelectric signal conversion; after the reference light is directly reflected on the oxygen sensitive film 600, the light signal is transmitted to the silicon photomultiplier tube 200 for processing to realize photoelectric signal conversion. The electrical signal converted by the silicon photomultiplier tube 200 is amplified by the signal amplifier, and the oscilloscope (OSCILLOSCOPE) reads the waveform of the corresponding phase of the electrical signal. The oscilloscope outputs the phase waveform to the PC terminal for data processing. In the above process, the phase change includes the phase difference between the optical path and the electronic path, and this difference is a fixed value, and there will be no additional phase lag. During measurement, the phase fed back by the reference light (for example, expressed as φ 1 ) and the phase of the feedback from the fluorescent indicator (e.g., φ 0 ) is used to replace the phase lag of fluorescence relative to the excitation light.
[0088] The above-mentioned brain oxygen sensor 10 can improve the accuracy of monitoring results and reduce the influence of factors such as light source fluctuations and leakage of fluorescent indicators. The above-mentioned brain oxygen sensor 10 uses a silicon photomultiplier tube 200 (Sipm) with a multi-pixel photon counter function for photoelectric signal processing, shortens the distance between the oxygen sensitive film 600 containing the fluorescent indicator and the photoelectric processor, so as to reduce the loss of optical signals during transmission and improve the accuracy of monitoring results. The utility model uses an excitation light source 400 and a reference light source 500, which can avoid the difference between the electronic path and the optical path caused by the structural assembly, use and maintenance in the traditional technology when a single excitation light source 400 is used, which directly affects the measurement results.
[0089] Second embodiment
[0090] Figure 3 is a schematic diagram of an exemplary configuration of a brain oxygen monitoring system including a brain oxygen sensor according to a second embodiment of the present invention. Figure 4 FIG. 1 is a schematic block diagram of a partial configuration of an intracranial monitoring system with an integrated brain oxygen sensor according to an embodiment of the present invention. Figure 3 As shown, a brain oxygen monitoring system is provided, including: a microcontroller MCU; a brain oxygen sensor connected to the microcontroller in communication; the brain oxygen sensor includes: a circuit board; a photoelectric conversion device mounted on the circuit board and electrically connected thereto, such as a silicon photomultiplier tube (Sipm); a filter (or a coated filter film) arranged (e.g., coated) on the surface of the silicon photomultiplier tube to filter out noise light; a biocompatible oxygen sensitive film stacked on the filter film, the oxygen sensitive film containing a fluorescent indicator; an excitation light LED and a reference light LED arranged separately from each other on the oxygen sensitive film. The fluorescent indicator is selected so that the fluorescence excited by the excitation light LED can be captured and processed by the photoelectric conversion device, and the microcontroller MCU sends a sinusoidal modulation signal at the same frequency to the excitation light LED (e.g., Figure 4 The blue LED shown) and the reference LED (eg Figure 4 The lifetime of the fluorescence is characterized by the phase difference between the light emitted by the reference light LED and the fluorescence excited by the excitation light LED at the same frequency. The brain oxygen monitoring system is configured to associate the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure with the phase difference to achieve the monitoring of the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure. The microcontroller MCU can be connected to a temperature sensor signal in the form of a thermistor (NTC), for example, and the intracranial temperature parameter measured by the temperature sensor can be used for temperature compensation / correction of the brain oxygen sensor.
[0091] In the above-mentioned brain oxygen monitoring system, the photoelectric conversion device, the filter film, the oxygen sensitive film, the excitation light LED and the reference light LED excitation light LED can be integrated as a whole.
[0092] In the above-mentioned brain oxygen monitoring system, the fluorescent indicator may be selected such that the wavelength and lifetime of the fluorescence are suitable for being captured and processed by the photoelectric conversion device.
[0093] like Figure 4As shown, an intracranial monitoring system with an integrated brain oxygen sensor is provided, the intracranial monitoring system comprising the brain oxygen monitoring system as described above; and a monitor (not shown), the monitor comprising a display for displaying physiological parameters of the monitored patient, the physiological parameters comprising the patient's brain tissue oxygen concentration and / or brain tissue oxygen partial pressure. The circuit board can be an electromagnetically compatible flexible circuit board (e.g., a flexible printed circuit board, FPC), and a pressure sensor for monitoring intracranial pressure and a temperature sensor for monitoring intracranial temperature can also be integrated on the flexible circuit board. The temperature sensor can be configured to also be used for temperature compensation of both the brain oxygen sensor and the pressure sensor.
[0094] like Figure 4 As further shown in the intracranial monitoring system, the temperature sensor in the temperature detection circuit is connected to the brain oxygen sensor through the communication circuit. In the photoelectric detection circuit, the excitation light LED (e.g. Figure 4 The blue light LED shown in FIG. 1 is electrically connected to the MCU through the LED driver circuit, and the reference light LED (eg Figure 4 The red LED shown in the figure is electrically connected to the MCU through the LED driving circuit. According to one example, in an intracranial monitoring (ICM) system, a brain oxygen sensor, a temperature sensor, a pressure sensor, corresponding signal acquisition and processing circuits, and optional other circuits and chips, such as a signal chain chip, etc., can be integrated on a circuit board of an intracranial pressure (ICP) probe of the intracranial monitoring (ICM) system.
[0095] One application scenario in which the brain oxygen monitoring system and brain oxygen sensor of the present invention can be applied is an intracranial monitoring (ICM) system and an intracranial pressure (ICP) probe. Exemplary examples and corresponding exemplary configurations and structures can be found in another invention patent application "Artificial intelligence-assisted intracranial monitoring system and bougie assembly" with patent application number 2023102231207 filed by the applicant on March 9, 2023. The relevant contents of this invention patent application are incorporated into this application by reference, just as if described in detail in this application.
[0096] Choice of fluorescent indicators and light sources
[0097] Fluorescence lifetime is an intrinsic parameter of the fluorescent indicator itself, which is not easily affected by external factors. The measurement method of fluorescence lifetime is selected to replace the measurement method of fluorescence intensity. Fluorescent indicators commonly used in the preparation of oxygen sensitive membranes are divided into three categories: polycyclic aromatic hydrocarbons, metal porphyrin complexes, and transition metal pyridine complexes. The excitation light wavelength and fluorescence wavelength of polycyclic aromatic hydrocarbons (pyrene, pyrene butyric acid) belong to the ultraviolet band, and the Stokes shift is small, which is not conducive to the miniaturization of the sensor and has a strong carcinogenic effect and is not suitable for implantation in the human body. Metal porphyrin complexes (PtOEP, PtTFPP) fluorescent indicators can be applied to the embodiments of the utility model, for example, as discussed in the first embodiment of the utility model, because this type of fluorescent indicator has a longer fluorescence lifetime (> 60) μs, and has relatively low requirements for light sources and detectors, etc., but its disadvantage is that the quantum yield is relatively low and is not conducive to the miniaturization of the sensor. Transition metal pyridyl complexes are more sensitive to oxygen changes and have less spectral overlap between the excitation wavelength and the fluorescence wavelength, so they are conducive to detection and measurement.
[0098] In this embodiment, a transition metal ruthenium complex, tris(4,7-biphenyl-1,10-phenanthroline)ruthenium dichloride (Ru(dpp) 3 Cl 2 ), as a fluorescent indicator, some of the concepts and reasons are described as follows.
[0099] After extensive investigation, testing and screening, the inventors surprisingly found that Figure 2 As shown, Ru(dpp) 3+ , namely, tris(4,7-biphenyl-1,10-phenanthroline)ruthenium dichloride (Ru(dpp) 3 Cl 2 ), the excitation wavelength and fluorescence wavelength can be 450nm and 600nm respectively, so Ru(dpp) 3+ The spectral overlap between the excitation light wavelength and the fluorescence wavelength is small, which is conducive to detection. Moreover, the fluorescence lifetime of 6.4μs is also sufficient to facilitate the capture and conversion of optical signals by subsequent optoelectronic devices. 3+ In the presence of silicon dioxide particles (SiO 2 ) after encapsulation, the PDMS gel mixture still has sufficient sensitivity, for example, its sensitivity parameter I 1 / I 100 It can reach 14.6, far exceeding others. Therefore, in this embodiment, the oxygen sensitive membrane is prepared by first dissolving the fluorescent indicator in ethanol and mixing it with the silicon dioxide particles, so that the particles are fully wrapped and dried, and then mixed with PDMS.
[0100] In this embodiment, a common LED on the market can be used as an excitation light source and a reference light source. LED as a light source can facilitate the miniaturization of the sensor and is inexpensive. According to an example, a blue LED (wavelength of 300-550nm) can be used as an excitation light source, and a red LED (wavelength of 380-660nm) can be used as a reference light source.
[0101] Phase difference detection and circuit part
[0102] After the fluorescent indicator is excited by a sinusoidally modulated excitation light source such as an LED, the phase difference between the excitation light signal of a specific modulation frequency and the fluorescent signal can be detected, and the phase difference can be calculated and defined as the fluorescence lifetime. The principle is as follows:
[0103] From the Stern-Volmer equation, we know that the ratio of fluorescence lifetime is:
[0104]
[0105] where τ 0 , τ are the fluorescence lifetimes without and with quencher, respectively, K sv is the quenching constant, and [Q] is the oxygen concentration of the quencher. From the formula, we can know that we only need to measure the ratio and quenching constant with and without the quencher to calculate the quencher concentration.
[0106] The fluorescence lifetime is the time required for the fluorescence intensity to decrease to 1 / e of the maximum fluorescence intensity when the light source is removed after the light source excites the oxygen sensitive membrane to produce fluorescence. The fluorescence intensity decays exponentially. The calculation formula is as follows:
[0107]
[0108] Where I(t) is the light intensity that varies with time, I 0 is the initial fluorescence intensity, t is the decay time, τ is the fluorescence lifetime, then the system function described by the linear system is:
[0109]
[0110] If the sinusoidal excitation light signal is modulated, then:
[0111] A(t)=Asin(2πft),
[0112] A is the amplitude of the sinusoidal modulation signal, f is the frequency of the sinusoidal modulation signal, π is a constant, and t is the time variable.
[0113] Assume that the excited fluorescence signal is the convolution of the modulated excitation light signal and the system function:
[0114] F(t)=A(t)*f(t),
[0115] Under ideal stable conditions:
[0116]
[0117] The phase difference θ between the fluorescence signals is manifested as a change in the fluorescence lifetime τ, and they have the following relationship: tanθ=2πfτ,
[0118] Among them, θ is the lag phase of the fluorescence signal, that is, the phase difference. f is the frequency of the sinusoidal modulation excitation signal and the generated fluorescence signal, and τ is the fluorescence lifetime.
[0119] Combining the Stern-Volmer equations, we can get:
[0120] where θ 0 is the phase of the fluorescence signal in anaerobic water, θ is the phase of the fluorescence signal when the dissolved oxygen concentration is [Q], that is, the calculated oxygen concentration can be regarded as directly related to the ratio of the phase tangent value of the fluorescence signal in anaerobic water to the phase tangent value of the fluorescence signal of the oxygen concentration to be measured.
[0121] The oxygen concentration / oxygen partial pressure can be further deduced based on the obtained phase difference θ value, thereby achieving evaluation / monitoring / measurement of the oxygen concentration / oxygen partial pressure, as described in detail below.
[0122] The implementation of phase difference detection is described in more detail below with reference to examples.
[0123] In this embodiment, the absorption and emission wavelengths of the fluorescent indicator can be 460nm and 600nm respectively, so a 460nm blue light LED is used as the excitation light source, and a 620nm red light LED is used as the reference light source. In terms of structure, according to an example, the excitation light LED and the reference light LED are arranged symmetrically to reduce the influence of the light path.
[0124] Use MCU to modulate and output sinusoidal wave signal: input the signal into a constant current source circuit including an operational amplifier and a MOS tube, and the circuit outputs a sinusoidal current signal to the LED light source, thereby controlling the excitation light LED and the reference light LED to emit sinusoidal light. 3+ The fluorescence lifetime is about 5μs, so the frequency of the sinusoidal wave signal applied to the LED light source should be greater than 2kHz.
[0125] An exemplary overall process is as follows:
[0126] 1) The blue LED is excited by a sine wave of x kHz (>2kHz) for y ms. The MCU collects the fluorescence signal and records the current phase φ 0 .
[0127] 2) Turn off the blue LED, turn on the reference red LED, drive the red LED with a sine wave of the same frequency, and drive yms in the same way. The MCU collects the reference light signal and records the time phase φ 1 .
[0128] 3) Since the time interval between the two lamps is very short, it can be assumed that the initial phases of the two lamps are the same, that is, φ 1 With φ 0 The difference between the two is the phase difference between the excitation light and the excited fluorescence.
[0129] The oxygen sensor / oxygen sensitive membrane can be calibrated by the standard solution calibration method, that is, the two-point calibration method:
[0130] 1) Place the prepared oxygen-free aqueous solution in 7-10 groups of constant temperature water tanks with different temperatures, and then insert the prepared oxygen sensor. After stabilization, record the phase difference between the fluorescence signal and the reference signal at multiple temperatures, calculate the phase difference tangent value at multiple points, and fit it with the temperature value to obtain the relationship between the phase tangent value of the fluorescence signal in the oxygen-free water and the temperature T, which is generally:
[0131] tan 无氧水 =a x T 3 +b x T 2 +c x T+x
[0132] where a x 、b x 、c x , x are the constants of the fitting curve under this condition, T is the actual temperature in the experiment, tan 无氧水 is the phase difference tangent value in the fitting curve.
[0133] 2) Place the prepared oxygen saturated solution in 7-10 groups of constant temperature water tanks with different temperatures, and then insert the prepared oxygen sensor. After stabilization, record the phase difference between the fluorescence signal and the reference signal at multiple temperatures, calculate the phase difference tangent value at multiple points, and fit it with the temperature value to obtain the relationship between the phase tangent value of the fluorescence signal in oxygen saturated water and the temperature T, which is generally:
[0134] tan 氧饱和水 =a y T 3 +b y T 2 +c y T+y
[0135] where a y 、b y 、c y, y are the constants of the fitting curve under this condition, T is the actual temperature under this experimental condition, tan 氧饱和水 is the phase difference tangent value in the fitting curve.
[0136] 3) Fitting the relationship between dissolved oxygen concentration and temperature in water under standard atmospheric pressure. The formula can be an objective formula, that is, a curve fitted after consulting the relationship between standard atmospheric pressure and dissolved oxygen concentration and temperature in water. The value can generally be fixed. The formula is generally:
[0137] C 0 (T) = a t T 3 +b t T 2 +c t T+z
[0138] Among them, C 0 (T) is the dissolved oxygen concentration, a t 、b t 、c t , Z are constants under this condition, T is the temperature, and the above values are substituted into the Stern-Volmer equation to obtain the dissolved oxygen concentration C 0 The quenching constant K at (T) sv ,Right now:
[0139]
[0140] In order to obtain K sv After the parameters are calculated, the oxygen concentration can be calculated, namely:
[0141]
[0142] Among them, tan Θ The phase difference tangent value and tan are obtained by calculating the phase difference measured in the current environment. 无氧水 is the phase difference tangent value, K calculated by substituting the current temperature value into the above oxygen-free water fitting curve sv is the constant obtained from the above calculation. After substituting all the values, the current dissolved oxygen concentration value [O 2 ].
[0143] If conversion into oxygen partial pressure is necessary, it can be converted as follows, for example.
[0144] According to Henry's law, oxygen concentration is proportional to oxygen partial pressure. If oxygen concentration is known, oxygen partial pressure can be calculated according to the following formula: C = P bt O 2 a, where C is oxygen concentration (mg / L); P bt O 2is the oxygen partial pressure (mmHg); a is the solubility coefficient (mg / mmHg·L). The solubility coefficient a is related to temperature.
[0145] Exemplary Configuration of Circuit Portion
[0146] The IV conversion circuit can be composed of, for example, the AD8642 chip and its peripheral circuits. Compared with other chips, the AD8610 has the characteristics of ultra-low offset voltage and drift, extremely low input voltage and current noise, extremely low input bias current and wide bandwidth. In actual use, the Sipm needs to be applied with a 30V voltage, and the voltage signal of the final signal reaching the op amp is relatively large, which has a large voltage range for the op amp. The maximum supply voltage of the AD8610 is ±13V, which can meet the needs.
[0147] The optical signal is converted into a current signal through Sipm, and the current signal is converted into a voltage signal through the AD8610 chip. The voltage signal is filtered out of the DC signal through the DC blocking capacitor, and then the signal is amplified and filtered. Finally, the optical signal excited by the sinusoidal current is converted into a sinusoidal voltage signal. Sipm will cause the gain to decrease with temperature changes. In actual situations, the impact of temperature on Sipm, in addition to the decrease in sensitivity, there are some more obvious problems such as noise, quenching resistance, and inter-electrode capacitance. Therefore, it is necessary to add a temperature compensation circuit to the circuit, and a corresponding temperature sensor can be configured in the brain oxygen monitoring system so that the monitoring results can be corrected / compensated.
[0148] Preparation of biocompatible oxygen-sensitive membrane
[0149] The membrane matrix (or carrier, matrix) of the biocompatible oxygen sensitive membrane is used to fix or carry and disperse the fluorescent indicator. It should generally have the following characteristics: good oxygen permeability and light transmittance, and be conducive to fluorescence spectrum measurement; be able to effectively load and evenly disperse the oxygen sensitive agent, and have chemical inertness, light stability and thermal stability; have a certain degree of flexibility, and can be made into thin films of various shapes, etc. The inventors surprisingly found that compared with other membrane matrices, Ru(dpp) 3+ , namely, tris(4,7-biphenyl-1,10-phenanthroline)ruthenium dichloride (Ru(dpp) 3 Cl 2 ), in the presence of silicon dioxide particles (SiO 2 ) after being wrapped, the gel mixture with polydimethylsiloxane (PDMS) has sufficient sensitivity (its sensitivity parameter I 1 / I 100=14.6), and can prevent the fluorescent dye from aggregating in the gel, facilitating the subsequent detection of fluorescent signals. Therefore, in this embodiment, a solution of a fluorescent indicator dissolved in ethanol is first mixed with silica particles, so that the particles are fully wrapped and dried, and then mixed with PDMS to make an oxygen sensitive membrane. According to an example, the preparation process of a biocompatible oxygen sensitive membrane is as follows.
[0150] 1) Fix the fluorescent indicator to the carrier / matrix: Take 200 mg of Ru(dpp) 3 Cl 2 The powder was dissolved in 10 ml of anhydrous ethanol; 2 g of SiO 2 The particles were added to 40 ml of sodium hydroxide aqueous solution and stirred at 1000 rpm for 30 minutes using a magnetic stirrer to prepare a silica gel solution. The ethanol solution containing the fluorescent indicator was poured into the silica gel solution and stirred at 1000 rpm for 30 minutes. The silica particles containing the dye were filtered out of the solution through a filter with a pore size of 0.45 μm, washed once in ethanol and three times in deionized water. All supernatant was removed and the SiO2 loaded with the fluorescent indicator was added to the silica gel solution. 2 The granules were dried at 70°C overnight.
[0151] 2) Fixation of oxygen sensitive membrane: The dried SiO 2 The powder (2 g) was mixed with PDMS (20 g) prepolymer part (part A) and 2 g PDMS curing agent part (part B) (Sylgard 184, Dow Corning) and then injected into the LED grooves and gaps, and then cured in a vacuum environment at 60°C for 7 days to remove solvents and bubbles. The cured film was stored at room temperature and away from light for at least 24 hours before use. A portion of the above groove, for example, can be prepared by mixing with a molten salt. Figure 1 The portion indicated by 600 between the middle light sources 400 and 500 has been filled with the oxygen sensitive film glue injection; the gap is for example Figure 3 As schematically shown in FIG. 1 , the filter / filter film arranged or coated on the Sipm includes a gap between the excitation light LED / reference light LED above it.
[0152] Integration of excitation light source, reference light source, fluorescent film and photoelectric processing device
[0153] In this embodiment, the photoelectric processing device can be a silicon photomultiplier (Sipm). Compared with ordinary photodiodes, Sipm can be composed of multiple avalanche photodiodes (APD) working in Geiger mode with a multi-pixel photon counter function. Although it is essentially an optical semiconductor, it has excellent photon counting capabilities and is suitable for monitoring occasions with extremely weak light at the photon counting level. It has the characteristics of low voltage operation, high photon detection efficiency, fast response, excellent time resolution and wide spectral response range, and can play the advantages of solid-state devices in resisting magnetic field interference and mechanical shock.
[0154] According to an example, in this embodiment, the photoelectric converter (optical signal processing device) can use ONSEMI's 10035 model silicon photomultiplier tube with multi-pixel photon counter function. APD is a high-speed, high-sensitivity photodiode. When a certain reverse bias is applied, it can avalanche amplify the photocurrent. When the reverse bias of the APD is set to be higher than the breakdown voltage, the internal electric field is stronger, and the photocurrent will obtain a gain of 105 to 106. This working mode is called the "Geiger mode" of the APD. Sipm is composed of multiple APDs working in Geiger mode connected in series with quenching resistors. In Geiger mode, photogenerated carriers will generate a large light pulse through multiplication, and single photons can be detected by detecting this pulse. Connecting an APD in Geiger mode to a quenching resistor as a pixel constitutes the basic unit of Sipm. The sum of its outputs constitutes the output of Sipm, and photon counting or signal strength measurement can be performed based on the output.
[0155] In this embodiment, for example, the excitation light source, the reference light source and the fluorescent film can be integrated with the optoelectronic processing device as follows:
[0156] 1) The filter film is directly coated and fixed on the surface of the silicon photomultiplier tube (SiPM) by, for example, an evaporation process to prevent it from being affected by other ambient light;
[0157] 2) Connect the reference light LED and the excitation light LED to the Sipm signal and fix them above the filter membrane;
[0158] 3) Pour the oxygen sensitive film prepared as described above into the gap between the filter film and the light source and / or the groove between the reference light LED and the excitation light LED, cure it in a vacuum environment to remove the solvent and bubbles, and store it at room temperature away from light for at least 24 hours to complete the overall integration.
[0159] The foregoing description of several embodiments of the utility model is presented for the purpose of illustration. The foregoing description is not intended to be exhaustive, nor is it intended to limit the utility model to the precise steps and / or forms disclosed. Obviously, according to the teachings above, the various technical features of the above-described embodiments can be combined in any technically feasible manner, and the embodiments can be modified and varied in many ways. The scope of the utility model and all equivalents are intended to be defined by the appended claims.
Claims
1. A brain oxygen monitoring system, comprising: Microcontroller; a brain oxygen sensor communicatively coupled to the microcontroller; Wherein, the brain oxygen sensor comprises: Electromagnetic compatible flexible circuit board; A photoelectric conversion device mounted on and electrically connected to the circuit board; A filter film coated on the surface of the photoelectric conversion device to filter out noise light; a biocompatible oxygen-sensitive membrane laminated on the filter membrane, wherein the oxygen-sensitive membrane contains a fluorescent indicator; an excitation light source and a reference light source which are separately arranged on the oxygen sensitive film; Wherein, the fluorescent indicator is selected so that the fluorescence excited by the excitation light source can be captured and processed by the photoelectric conversion device; Wherein, the lifetime of the fluorescence is characterized by the phase difference between the light emitted by the reference light source and the fluorescence excited by the excitation light source at the same frequency; Wherein, the brain oxygen monitoring system is configured to associate the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure with the phase difference to achieve monitoring of the brain tissue oxygen concentration and / or the brain tissue oxygen partial pressure; Wherein, the wavelength of the excitation light source is 300-550nm; the wavelength of the reference light source is 380-660nm; and Wherein, the photoelectric conversion device, the filter film, the oxygen sensitive film, the excitation light source and the reference light source are integrated into an integral structure.
2. The brain oxygen monitoring system according to claim 1, wherein: The excitation light source and the reference light source are photodiodes or LEDs, and the photoelectric conversion device includes a silicon photomultiplier tube.
3. The brain oxygen monitoring system according to claim 2, wherein: The silicon photomultiplier tube is a silicon photomultiplier tube with a multi-pixel photon counter function, and is composed of a plurality of avalanche photodiodes working in a Geiger mode.
4. The brain oxygen monitoring system according to claim 2, wherein: The excitation light source and the reference light source are an excitation light LED and a reference light LED, respectively; and The filter film, the oxygen sensitive film, the excitation light LED and the reference light LED are integrated on the silicon photomultiplier tube through coating and packaging.
5. The brain oxygen monitoring system according to any one of claims 1 to 4, wherein: The brain oxygen monitoring system is configured to control the light emission of both the excitation light source and the reference light source by modulating a current signal of a sine wave with the same frequency through the microcontroller and the circuit board.
6. An intracranial monitoring system, characterized in that: The intracranial monitoring system comprises a brain oxygen monitoring system according to any one of claims 1-5; and a monitor, wherein the monitor comprises a display for displaying physiological parameters of the monitored patient, the physiological parameters comprising the patient's brain tissue oxygen concentration and / or brain tissue oxygen partial pressure.
7. The intracranial monitoring system according to claim 6, characterized in that: A pressure sensor for monitoring intracranial pressure and a temperature sensor for monitoring intracranial temperature are also integrated on the flexible circuit board; wherein the temperature sensor is configured to also be used for temperature compensation of both the brain oxygen sensor and the pressure sensor.
8. The intracranial monitoring system according to claim 7, characterized in that: The temperature sensor is a temperature sensor in the form of a negative temperature coefficient thermistor.
Citation Information
Cited By
Implantable plasma concentration real-time monitoring equipment for surgical anesthesia
CN121265037A
